Department of Gastroenterological Surgery, Cancer Institute Ariake Hospital, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Gastric Cancer. 2020 Mar;23(2):328-338. doi: 10.1007/s10120-019-01000-3. Epub 2019 Aug 26.
The proportion of elderly patients undergoing surgery for gastric cancer is increasing. However, limited number of therapeutic outcomes in the elderly has been reported. Here we examined the surgical results based on a nationwide survey of elderly patients who underwent surgery for Stage I gastric cancer.
Data from 68,353 Stage I patients who underwent gastrectomy between 2001 and 2007 were retrospectively collected. The accumulated data were reviewed and analyzed by the Japanese Gastric Cancer Association registration committee. We first classified the patients as those aged ≤ 74 years and ≥ 75 years. We further classified those patients aged ≥ 75 years into groups by 5-year increments to examine their short- and long-term postoperative outcomes.
Patients aged ≥ 75 years accounted for 46.5%. The 30-day mortality rate was < 0.7% for any age group, but for those aged ≥ 75 years, the 60-day and 90-day mortality rates were 0.9-2.3% and 1.2-5.1%, respectively. An examination of long-term survival indicated that, as the class of age increased, the 5-year overall survival (OS) was 47.0-93.1% and disease-specific survival (DSS) was 91.4-98.2%, respectively. Although high DSS rates of ≥ 90% were found for all age groups, OS only accounted for ≤ 82% of patients aged ≥ 75 years.
Among elderly patients with Stage I gastric cancer, deaths due to other diseases were frequently observed in the long term. Thus, for elderly patients, it may be appropriate to reconsider the treatment strategy with respect to the balance between the invasiveness of the treatment and the prognosis.
接受胃癌手术的老年患者比例正在增加。然而,目前报道的老年患者治疗结果数量有限。在这里,我们根据对接受 I 期胃癌手术的老年患者进行的全国性调查,检查了手术结果。
回顾性收集了 2001 年至 2007 年间接受胃切除术的 68353 例 I 期患者的数据。日本胃癌协会注册委员会对累积数据进行了审查和分析。我们首先将患者分为年龄≤74 岁和≥75 岁的患者。我们进一步将≥75 岁的患者分为 5 岁一组,以检查他们的短期和长期术后结果。
≥75 岁的患者占 46.5%。任何年龄组的 30 天死亡率都<0.7%,但≥75 岁的患者的 60 天和 90 天死亡率分别为 0.9-2.3%和 1.2-5.1%。对长期生存的检查表明,随着年龄组的增加,5 年总生存率(OS)分别为 47.0-93.1%和疾病特异性生存率(DSS)分别为 91.4-98.2%。尽管所有年龄组的 DSS 率均>90%,但 OS 仅占≥75 岁患者的≤82%。
在 I 期胃癌的老年患者中,长期观察到其他疾病导致的死亡。因此,对于老年患者,可能需要重新考虑治疗策略,以平衡治疗的侵袭性和预后。